D. E. Shaw & Co. Inc. Decreases Holdings in USANA Health Sciences, Inc. (USNA)

D. E. Shaw & Co. Inc. trimmed its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 0.7% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 113,581 shares of the company’s stock after selling 774 shares during the quarter. D. E. Shaw & Co. Inc. owned approximately 0.47% of USANA Health Sciences worth $13,372,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of USNA. Matarin Capital Management LLC bought a new stake in USANA Health Sciences in the third quarter valued at $18,159,000. Vanguard Group Inc lifted its stake in USANA Health Sciences by 10.7% in the third quarter. Vanguard Group Inc now owns 1,245,807 shares of the company’s stock valued at $150,182,000 after buying an additional 120,709 shares during the last quarter. Vanguard Group Inc. lifted its stake in USANA Health Sciences by 10.7% in the third quarter. Vanguard Group Inc. now owns 1,245,807 shares of the company’s stock valued at $150,182,000 after buying an additional 120,709 shares during the last quarter. BlackRock Inc. increased its holdings in shares of USANA Health Sciences by 11.8% during the third quarter. BlackRock Inc. now owns 1,076,327 shares of the company’s stock valued at $129,750,000 after purchasing an additional 113,961 shares during the period. Finally, Sensato Investors LLC increased its holdings in shares of USANA Health Sciences by 277.1% during the third quarter. Sensato Investors LLC now owns 108,984 shares of the company’s stock valued at $13,138,000 after purchasing an additional 80,084 shares during the period. Institutional investors own 53.37% of the company’s stock.

In related news, Director Gilbert A. Fuller sold 282 shares of USANA Health Sciences stock in a transaction dated Monday, February 11th. The stock was sold at an average price of $110.20, for a total transaction of $31,076.40. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Myron W. Wentz sold 20,645 shares of USANA Health Sciences stock in a transaction dated Friday, February 1st. The stock was sold at an average price of $115.36, for a total value of $2,381,607.20. The disclosure for this sale can be found here. Insiders have sold 60,564 shares of company stock worth $6,990,279 over the last three months. Corporate insiders own 42.50% of the company’s stock.

Shares of USNA traded down $0.36 during trading hours on Monday, reaching $84.72. 185,000 shares of the company’s stock traded hands, compared to its average volume of 193,761. The firm has a market capitalization of $1.98 billion, a price-to-earnings ratio of 16.42 and a beta of 0.32. USANA Health Sciences, Inc. has a twelve month low of $75.27 and a twelve month high of $137.95.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, February 5th. The company reported $1.32 EPS for the quarter, missing analysts’ consensus estimates of $1.33 by ($0.01). The business had revenue of $299.02 million for the quarter, compared to analyst estimates of $305.79 million. USANA Health Sciences had a net margin of 10.61% and a return on equity of 30.49%. USANA Health Sciences’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same period last year, the business posted $1.11 earnings per share. On average, research analysts expect that USANA Health Sciences, Inc. will post 5.18 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This news story was first posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.baseballdailydigest.com/news/2019/04/15/d-e-shaw-co-inc-lowers-position-in-usana-health-sciences-inc-usna.html.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.

Read More: Why is total return important?

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.